Objective Evaluation of the Effect of Oculoplastic Operations Using the Vectra M 3D Imaging System
NCT ID: NCT06040671
Last Updated: 2023-09-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2021-05-03
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot Study
NCT01843101
Retinal Investigation Using Optos OCT Device
NCT06846151
oCular Examination at Cell RESolution With Optical TransmissionTomography
NCT06976034
Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures
NCT03461978
Objective Assessment of Macular Function at Retinal and Cortical Levels
NCT03517241
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Different files will be created where the effect of different operations will be monitored in parallel.
Lateral canthal hinge surgery will be evaluated in the pilot group, and ptosis surgery through an anterior approach will be evaluated in the second group.
In all patients, the position of the eyelids, their change before and after surgery, the periorbital volume, and the relation of the eyelids to the periorbital landscape will be assessed metrically.
The Vectra M3 device will be used for the measurement.
The expected cohort size is 40 patients in each group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lateral canthal hinge surgery patients
Patients undergoing lateral canthal hinge surgery will be enrolled in this group.
Vectra M3 imaging
Study subjects from both arms will undergo Vectra M3 imaging to evaluate the result of the surgery.
Ptosis surgery patients
Patients undergoing ptosis surgery will be enrolled in this group.
Vectra M3 imaging
Study subjects from both arms will undergo Vectra M3 imaging to evaluate the result of the surgery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vectra M3 imaging
Study subjects from both arms will undergo Vectra M3 imaging to evaluate the result of the surgery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Eyelid entropion
* Eyelid ectropion
Exclusion Criteria
* Not signing the Informed Consent Form
* Inability/reluctance to cooperate in the study
4 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Ostrava
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adam Kopecký, MD,PhD,FEBO
Role: PRINCIPAL_INVESTIGATOR
University Hospital Ostrava
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Ostrava
Ostrava, Moravian-Silesian Region, Czechia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
28/RVO-FNOs/2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.